ResearcherVanderbilt UniversityNo recent work listed
Xiang Shu
Matched on ORCID iD 0000-0002-4129-9403; OpenAlex author ID A5058650746. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 32
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper
Papers 3
- Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-21-0400↗
- Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. First author DOI 10.1158/1055-9965.epi-20-0091↗
- Prospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk. Co-author DOI 10.1002/ijc.31574↗
Closest collaborators
The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wei Zheng · 3 shared papers, 2018–2021 · strength 0.25
- Paper Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk. DOI 10.1158/1055-9965.epi-21-0400↗
- Paper Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. DOI 10.1158/1055-9965.epi-20-0091↗
- Paper Prospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk. DOI 10.1002/ijc.31574↗
- Xiao‐Ou Shu · 3 shared papers, 2018–2021 · strength 0.25
- Paper Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk. DOI 10.1158/1055-9965.epi-21-0400↗
- Paper Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. DOI 10.1158/1055-9965.epi-20-0091↗
- Paper Prospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk. DOI 10.1002/ijc.31574↗
- Jirong Long · 2 shared papers, 2020–2021 · strength 0.18
- Lang Wu · 2 shared papers, 2020–2021 · strength 0.18
- Jingjing Zhu · 2 shared papers, 2020–2021 · strength 0.18
- Duo Liu · 2 shared papers, 2020–2021 · strength 0.18
- Qiuyin Cai · 2 shared papers, 2020–2021 · strength 0.18
- Dominique S. Michaud · 1 shared paper, 2021 · strength 0.11
- Douglas W. Mahoney · 1 shared paper, 2021 · strength 0.11
- John B. Kisiel · 1 shared paper, 2021 · strength 0.11
- Eric J. Duell · 1 shared paper, 2020 · strength 0.07
- Roger Laughlin Milne · 1 shared paper, 2020 · strength 0.07
- Mengmeng Du · 1 shared paper, 2020 · strength 0.07
- Rachel Ε. Neale · 1 shared paper, 2020 · strength 0.07
- Federico Canzian · 1 shared paper, 2020 · strength 0.07
- Stephen K. Van Den Eeden · 1 shared paper, 2020 · strength 0.07
- Verena Andrea Katzke · 1 shared paper, 2020 · strength 0.07
- Emily White · 1 shared paper, 2020 · strength 0.07
- Herbert Yu · 1 shared paper, 2020 · strength 0.07
- Núria Malats Riera · 1 shared paper, 2020 · strength 0.07
- Rachael Z. Stolzenberg‐Solomon · 1 shared paper, 2020 · strength 0.07
- Alison P. Klein · 1 shared paper, 2020 · strength 0.07
- Harvey A. Risch Risch · 1 shared paper, 2020 · strength 0.07
- Ghislaine Scélo · 1 shared paper, 2020 · strength 0.07
- Steve Gallinger · 1 shared paper, 2020 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.